Featured Products & Services

1. Nasal Dosage Form Development 10/23/2024

   Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.

2. Controlled Expansion Of Supercritical Solutions (CESS®) Technology 4/24/2023

   Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.

3. Isolator Barrier Pharmaceutical Aseptic Filling Systems 11/12/2020

   ASEPTiCell is integrated with isolator-barrier technologies to fully enclose and tightly control the aseptic environment for ideal conditions for processing sterile drug products. The system can be configured with a Restricted Access Barrier System (RABS) or an aseptic isolator to provide uninterrupted aseptic conditions during production. With isolator integrated systems, the ASEPTiCell is completely compatible with repeated in-situ bio-decontamination using hydrogen peroxide to further enhance the sterility assurance of the system.

4. Cartridges For Use In Drug Delivery Applications

   Predictable, Reliable, Versatile. West offers Daikyo Crystal Zenith^® cartridges used in drug delivery applications. These cartridges are manufactured with the highest dimensional tolerances ensuring this cartridge technology is predictable and safe. Daikyo Crystal Zenith offers superior performance by using a polymer with proven functionality, safety, and compatibility for a variety of devices making it suitable for high-viscosity drugs and long-term storage.

5. Pharmaceutical Vial Filling Equipment: VFM 4/28/2021

   VFM automatic filling and stoppering machines are designed for injectable solutions in vials.

6. Oral Dosage Form Development 10/23/2024

   Oral administration remains the most widely used route for the successful delivery of active pharmaceuticals to patients.

7. cGMP Aseptic Manufacturing And Sterile Fill-Finish 1/28/2022

   Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.

8. Formulations For Poorly Soluble And Low Bioavailability Drugs 1/28/2022

   Ascendia specializes in the development of market suitable formulations for poorly water soluble drug substances. Based on the pre-formulation data package and the delivery requirements for the product, we recommend a comprehensive formulation development strategy. We understand that each formulation is unique and must address the specific challenges associated with poor solubility, inadequate bioavailability, and/or unacceptable physical/chemical stability. We also understand the urgency companies have for progressing their pipeline, and our approach maximizes the probability of success by exploring multiple formulation options in parallel if necessary.

9. Pharmaceutical Sterile Filling Systems For Eye Drops And Ophthalmic Products 8/3/2020

   Filling and capping machine for eye-drop bottles.

10. Injection Molding 8/24/2020

    Capabilities that improve efficiency and accelerate development.

    B. Braun's OEM Division offers a variety of in-house molding capabilities including injection molding, insert molding and over molding. They own a primary 400,000-square-foot U.S. plant that includes a 16,500-square-foot ISO Class 8 molding facility housing some of B. Braun’s 80 injection molding presses, which range from 55-330 tons.